Integra LifeSciences (IART) Stock Forecast & Price Target

IART$14.40+0.05 +0.35%
Medical - DevicesValue StockHigh Quality
Compare
Market cap$1.12BEnterprise value$2.80BRevenue (TTM)$1.66BMarket position—

Score

69
Bullish
Value
82
Quality
65
Growth
59

Integra LifeSciences Holdings Corporation price target

IART
Low$13.00
Average$15.80
High$25.00
Upside vs current price+9.7%

The average target of $15.80 is +9.7% versus the current IART price of $14.40.

Integra LifeSciences Holdings Corporation analyst ratings

RatingAnalysts
Strong buy1
Buy2
Hold7
Sell0
Strong sell2
ConsensusHold

12 analysts cover IART.

Integra LifeSciences Holdings Corporation EPS and revenue estimates

The estimate table for the Integra LifeSciences Holdings Corporation keeps 2026 EPS $2.34, 2027 EPS $2.39, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$2.34$1.64B
2027$2.39$1.67B

Is Integra LifeSciences Holdings Corporation a buy or sell?

Of the 12 analysts covering Integra LifeSciences Holdings Corporation, 3 rate it a buy (1 strong buy and 2 buy), 7 rate it a hold, and 2 rate it a sell (0 sell and 2 strong sell).

The IART consensus label is Hold, beside 3 buy-side ratings and 2 sell-side ratings.

The average target of $15.80 implies +9.7% versus the current price of $14.40.

the Integra LifeSciences Holdings Corporation closes with 3 buy-side ratings and 2 on the sell side. The headcount is Hold.

Reading the Integra LifeSciences Holdings Corporation forecast

Analysts are far apart on IART. The published low is $13.00, the average is $15.80, and the high is $25.00.

From today's $14.40 print, the IART average target is +9.7% away.

IART coverage does not pile into one bucket: 3 of 12 analysts are on the buy side, 7 are at hold, and 2 are on the sell side, and the published consensus is Hold.

IART targets have eased: $13.50 in the last month against $13.80 over the last quarter.

IART coverage is thin at 12 analysts, and one revision moves the average.

Integra LifeSciences Holdings Corporation forecast questions

What is the IART price target?

The published range for IART is $13.00 to $25.00, with an average of $15.80. That average is +9.7% versus the current price of $14.40.

Is Integra LifeSciences Holdings Corporation a buy or sell?

Of the 12 analysts covering Integra LifeSciences Holdings Corporation, 3 rate it a buy, 7 rate it a hold, and 2 rate it a sell. The consensus is Hold, which for IART is 3 on the buy side, 7 at hold, and 2 on the sell side.

What is the EPS estimate for Integra LifeSciences Holdings Corporation?

Analyst EPS estimates for Integra LifeSciences Holdings Corporation: 2026 $2.34, 2027 $2.39.

What is the revenue estimate for Integra LifeSciences Holdings Corporation?

Analyst revenue estimates for Integra LifeSciences Holdings Corporation: 2026 $1.64B, 2027 $1.67B.

How many analysts cover IART?

12 analysts cover IART. Their consensus on IART is Hold, across those 12.

IART price $14.40 +0.05 +0.35%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener